The DOI matches its Crossref record; 206 of the 207 references it cites were found in a registry or an index.
The Pathophysiology of Fragile X (and What It Teaches Us about Synapses)
Open accessAbstract
Fragile X is the most common known inherited cause of intellectual disability and autism, and it typically results from transcriptional silencing of FMR1 and loss of the encoded protein, FMRP (fragile X mental retardation protein). FMRP is an mRNA-binding protein that functions at many synapses to inhibit local translation stimulated by metabotropic glutamate receptors (mGluRs) 1 and 5. Recent studies on the biology of FMRP and the signaling pathways downstream of mGluR1/5 have yielded deeper insight into how synaptic protein synthesis and plasticity are regulated by experience. This new knowledge has also suggested ways that altered signaling and synaptic function can be corrected in fragile X, and human clinical trials based on this information are under way.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FMRP has recently been reported to modulate the rate of translational elongation of mRNAs that encode synaptic proteins33, suggesting that the decrease in FMRP expression that occurs in Fragile X syndrome may result in the dysregulation of synaptic protein expression owing to an impairment in translational control23.”
From Activity-dependent neuronal signalling and autism spectrum disorder (2013) · cites this paper as [23]
In the citing paper
“Fragile X syndrome results from a trinucleotide expansion (CGG) in FMR1, which encodes fragile X mental retardation protein (FMRP).”
From Activity-dependent neuronal signalling and autism spectrum disorder (2013) · cites this paper as [23]
In the citing paper
“The CGG expansion occurs within the 5′ untranslated region of the FMRP mRNA, resulting in decreased translation of the FMRP mRNA and a decrease in the amount of FMRP expressed in neurons.”
From Activity-dependent neuronal signalling and autism spectrum disorder (2013) · cites this paper as [23]
In the citing paper
“In addition to these rare mutations, several widely studied syndromic disorders, such as Fragile X, with penetrant autism spectrum features have provided useful insight into the pathophysiology of ASD.”
From Activity-dependent neuronal signalling and autism spectrum disorder (2013) · cites this paper as [23]
In the citing paper
“For example, Fragile X syndrome — characterized by macroorchidism, connective-tissue disease, motor abnormalities, language deficits and impaired social interactions — is the leading cause of inherited intellectual disability and ASD23.”
From Activity-dependent neuronal signalling and autism spectrum disorder (2013) · cites this paper as [23]
In the citing paper
“This protein negatively regulates the translation of specific mRNAs at the synapse23,54.”
From Activity-dependent neuronal signalling and autism spectrum disorder (2013) · cites this paper as [23]
In the citing paper
“Several genes that are mutated in ASD — FMR1, TSC1, TSC2 and PTEN — have key roles in protein synthesis-dependent plasticity of synapses (Fig. 2)13,23.”
From Activity-dependent neuronal signalling and autism spectrum disorder (2013) · cites this paper as [23]
In the citing paper
“These findings are the basis of human clinical trials that aim to test the efficacy of mGluR5 antagonists for the treating Fragile X syndrome23,56–58.”
From Activity-dependent neuronal signalling and autism spectrum disorder (2013) · cites this paper as [23]
In the citing paper
“This suggests that these ASD candidate genes and FMRP may function in overlapping pathways.”
From Activity-dependent neuronal signalling and autism spectrum disorder (2013) · cites this paper as [23]
In the citing paper
“Many other FMRP targets have been shown to be involved in synaptic plasticity, and there is significant overlap between FMRP targets and ASD candidate genes, including NLGN3, NRXN1, SHANK3, PTEN, TSC1 and NF123,33.”
From Activity-dependent neuronal signalling and autism spectrum disorder (2013) · cites this paper as [23]
In the citing paper
“As the Ras–MAPK signalling pathway is crucial for activity-regulated protein synthesis, activity-dependent gene transcription and mGluR dependent synaptic plasticity23,25,95”
From Activity-dependent neuronal signalling and autism spectrum disorder (2013) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The molecular biology of memory storage: a dialogue between genes and synapses
Kandel, E. R. (2001) · Science · doi:10.1126/science.1067020 · Cited by 3,917
Verkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481
Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Pieretti, M., Sutcliffe, J. S., Richards, S., Verkert, A. J. M. H., Holden, J. J. A., Fenwick, R. G., Warren, S. T., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90283-5 · Cited by 2,080
FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism
Darnell, J. C., Van Driesche, S. J., Zhang, C., Hung, K. Y. S., Mele, A., Fraser, C. E., Stone, E. F., Chen, C., Fak, J. J., Chi, S. W., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.013 · Cited by 2,072
Ferguson, S. S. G. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01478-9 · Cited by 1,827
The mGluR theory of fragile X mental retardation
Bear, M. F., Huber, K. M., & Warren, S. T. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.04.009 · Cited by 1,580
Self-citationAbsence of expression of the FMR-1 gene in fragile X syndrome
Pieretti, M., Zhang, F., Fu, Y.-H., Warren, S. T., Oostra, B. A., Caskey, C. T., & Nelson, D. L. (1991) · Cell · doi:10.1016/0092-8674(91)90125-i · Cited by 1,476
Altered synaptic plasticity in a mouse model of fragile X mental retardation
Huber, K. M., Gallagher, S. M., Warren, S. T., & Bear, M. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122205699 · Cited by 1,349
Self-citationBrown, V., Jin, P., Ceman, S., Darnell, J. C., O'Donnell, W. T., Tenenbaum, S. A., Jin, X., Feng, Y., Wilkinson, K. D., Keene, J. D., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00568-2 · Cited by 1,109
Fmr1 knockout mice: A model to study fragile X mental retardation
THEDUTCHBELGIANFRAGILEXCONSOR (1994) · Cell · doi:10.1016/0092-8674(94)90569-x · Cited by 1,108
Research works printed but not linked: 5
- Caudy AA, 2004, Methods Mol. Biol., 265, 59
- Dutch-Belgian Fragile X Consort, 1994, Cell, 78, 23
- Loesch DZ, 1995, Am. J. Hum. Genet., 57, 1408
- Meredith RM, 2010, Front. Synaptic Neurosci., 2, 10
- Westmark CJ, 2009, Int. J. Clin. Exp. Pathol., 3, 56
Cited by
Sorted by citations
Items 301–366 of 366
Geng, J., Wang, X., Pan, J., Khan, D., Pimcharoen, S., Zhang, Y., Mosammaparast, N., Hirose, S., Petrucelli, L., Brandman, O., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adq3551 · Cited by 4
Dendritic Targeting and Regulatory RNA Control of Local Neuronal Translation
Eom, T., Muslimov, I. A., Iacoangeli, A., & Tiedge, H. (2018) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190686307.013.8 · Cited by 4
Nomura, Y., Nomura, J., Kamiguchi, H., Nishikawa, T., & Takumi, T. (2021) · Neuroscience Research · doi:10.1016/j.neures.2021.03.005 · Cited by 4
Molecular Mechanisms of Neurological Disease
Gireud, M., Sirisaengtaksin, N., & Bean, A. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397179-1.00021-x · Cited by 5
m6A in RNA: a key regulator of brain development, function and disease
Sivasudhan, E., & Meyer, K. D. (2026) · Nature reviews. Neuroscience · doi:10.1038/s41583-026-01056-y · Cited by 3
The association of FMR1 gene (CGG)n variation with idiopathic female infertility
Grasmane, A., Rots, D., Vitina, Z., Magomedova, V., & Gailīte, L. (2019) · Archives of Medical Science · doi:10.5114/aoms.2019.85154 · Cited by 3
Stanfield, A. C., & McKechanie, A. G. (2025) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2025.2510408 · Cited by 3
Zhang, Z., Keyser, C., Li, Y., Rosolia, B. J., Porch, M. W., Zhang, W., Su, B., Peng, J. C., Zukin, R. S., & Yan, J. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03207-6 · Cited by 3
Sorrell, M. R. J., & Killian, K. A. (2020) · Journal of Insect Physiology · doi:10.1016/j.jinsphys.2020.104097 · Cited by 3
Post-transcriptional Regulation by Brain-Derived Neurotrophic Factor in the Nervous System
Amen, A. M., Pham, D. L., & Meffert, M. K. (2015) · Springer eBooks · doi:10.1007/978-3-319-25124-0_14 · Cited by 3
Culp, M. J., Rosolia, B. J., Keyser, C., & Yan, J. (2025) · Biomedicines · doi:10.3390/biomedicines13102518 · Cited by 2
Takeda, R., Ishii, R., Parvin, S., Shiozawa, A., Nogi, T., & Sasaki, Y. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137317 · Cited by 2
Fink, J. J., Delaney-Busch, N., Dawes, R. P., Nanou, E., Folts, C. J., Harikrishnan, K., Hempel, C. M., Upadhyay, H., Nguyen, T. M., Shroff, H., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-07120-6 · Cited by 2
Self-citationFMR1 genetically interacts with DISC1 to regulate glutamatergic synaptogenesis
Honda, T., Kurita, K., Arai, Y., Pandey, H., Sawa, A., & Furukubo-Tokunaga, K. (2024) · Schizophrenia · doi:10.1038/s41537-024-00532-7 · Cited by 2
Wang, S. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1618438 · Cited by 2
Taurine up-regulated gene 1 and disease development.
Fu, C., Chen, M., Hu, S., & Huang, J. (2020) · PubMed · doi:10.11817/j.issn.1672-7347.2020.190181 · Cited by 2
Epigenetics and Epigenomics in Human Health and Disease
Festenstein, R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-420196-5.00005-8 · Cited by 2
Chloride imbalance in Fragile X syndrome
Miles, K. D., & Doll, C. A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1008393 · Cited by 1
From Molecular Pathways to ASD Therapy: Insights from Syndromic Forms of Autism
Nicholls, L. E., Ramadas, R., & Voineagu, I. (2014) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814602167_0002 · Cited by 1
Complex Neurodevelopmental Disorders And Their Genetic Etiologies
Batool, A., & Arooj, M. (2016) · International journal of scientific and technology research · Cited by 1
Implication of the endocannabidiome and metabolic pathways in fragile X syndrome pathophysiology
Dionne, O., Abolghasemi, A., Corbin, F., & Çaku, A. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.115962 · Cited by 1
Tsotsokou, G., Miliou, A., Trompoukis, G., Leontiadis, L. J., & Papatheodoropoulos, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136975 · Cited by 1
Lakhani, A., Huang, W., Rodgers, C. C., & Wenner, P. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106837 · Cited by 1
Cell Type-Specific Assessment of Cholesterol Distribution in Models of Neurodevelopmental Disorders
Dixit, S., Czernecki, C., Riezman, I., Innocenti, S., Bornmann, C., Guérard, L., Pfrieger, F. W., Riezman, H., & Scheiffele, P. (2026) · Journal of Neuroscience · doi:10.1523/jneurosci.1339-26.2026 · Cited by 1
Control of recollection by slow gamma dominating mid-frequency gamma in hippocampus CA1Preprint
Dvorak, D., Radwan, B., Sparks, F. T., Talbot, Z. N., & Fenton, A. A. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/152488 · Cited by 1
To Translate or Degrade: Cytoplasmic mRNA Decision Mechanisms
Beisang, D. J., & Bohjanen, P. R. (2014) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.201300011
The function of TCF4 in Pitt-Hopkins syndrome and schizophrenia
Forrest, M. P. (2013) · ORCA Online Research @Cardiff (Cardiff University)
Levantamento de proteínas candidatas a ativadoras do splicing do éxon 12 do gene FMR1
de Campos, M. V. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.41.2014.tde-26082014-152426
Implicancias del gen FMR1 en la función ovárica
Ferder, I. C. (2014) · Repositorio Digital Institucional de la Universidad de Buenos Aires (Universidad de Buenos Aires)
Osherovich, L. Z. (2013) · Science-Business eXchange · doi:10.1038/scibx.2013.129
Ethnopharmacological and genetic study on the treatment of mental disorders: a systematic review
Lima, C. K. T., Pontes, L. Q., Pinho, L. G., Bezerra, M. R. L., Barroso, W. D. S., Júnior, A. G. T., Alves, M. N. T., Macedo, J. C. B., Feitosa, U. N. S., Neto, J. L. D. A., et al. (2015) · International Archives of Medicine · doi:10.3823/1787
Form follows function: actin-binding proteins as critical regulators of excitatory synapses
Rust, M. B., & Michaelsen‐Preusse, K. (2016) · e-Neuroforum · doi:10.1007/s13295-015-0019-6
FMRP and the Pathophysiology of Fragile X Syndrome
Barnes, S. A., Thomson, S. R., Kind, P. C., & Osterweil, E. K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800109-7.00008-x
Virus-mediated Delivery of the Fmr1 Gene as a Tool for the Treatment of Fragile X Syndrome
Moghaddam, S. G. (2016) · TSpace (University of Toronto)
The Endocannabinoid System in Fragile X Syndrome
Martin, H. G. S., Neuhofer, D., & Manzoni, O. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804461-2.00012-3
Role of retinoic acid signaling in homeostatic synaptic plasticity
Sarti, F. (2013) · eScholarship (California Digital Library)
Profilin isoforms in the hippocampus in health and disease
Zessin, S. (2014) · Digitale Bibliothek Braunschweig (Verbundzentrale Göttingen (VZG)) · doi:10.24355/dbbs.084-201501221125-0
Moment-to-moment regulation of voltage-gated potassium channel function
Baronas, V. A. (2018) · cIRcle (University of British Columbia) · doi:10.14288/1.0368851
Cooperative Regulation of Translational Repression by FMRP and the miRNA Pathway
Kaul, N. (2018) · Digital Commons - DU (University of Denver)
Notaras, M. J., Allen, M., Longo, F., Volk, N. L., Tóth, M., Jeon, N. L., Klann, E., & Colak, D. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/389585
Maussion, G., Rocha, C., Pimentel, L. S. B., Beitel, L. K., & Durcan, T. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85764-2.00007-7
Post-transcriptional Regulation of Myelin Basic Protein Expression
Giampetruzzi, A. (2014) · OpenCommons at University of Connecticut (University of Connecticut)
Chelly, J. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717992196.793473535
Kaufmann, S. H. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727160484.793565201
Humanização em terapia intensiva - Aspectos iniciais
Ferreira, F. H. (2021) · Editora Conhecimento Livre eBooks · doi:10.37423/210403979
Prion Protein Complex with mGluR5 Mediates Amyloid-ß Synaptic Loss in Alzheimer’s Disease
Roseman, G. P., Fu, L., & Strittmatter, S. M. (2023) · Springer eBooks · doi:10.1007/978-3-031-20565-1_22
(2023) · The MIT Press eBooks · doi:10.7551/mitpress/15380.003.0024
Understanding the Neurobiological Components of Neurodevelopmental Disorders
Thompson, B. L. (2024) · Contemporary clinical neuroscience · doi:10.1007/978-3-031-66932-3_6
Analysis of ribosomes from WT and FMR1 KO human embryonic stem cellsPreprint
Kharbanda, T., D’Souza, M. N., Palakodeti, D., Muddashetty, R. S., & Vinothkumar, K. R. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.18.624098
Kassir, M. H., Lovelace, J. W., Binder, D. K., Ethell, I. M., & Razak, K. A. (2025) · ASN NEURO · doi:10.1080/17590914.2025.2564628
Non-CGG trinucleotide repeat expansions as pathogenic genetic mutations in Fragile X SyndromePreprint
da Cruz, A. C. P., Ferrasa, A., Masson, I. D. N., de Souza, J. S., Rodrigues, K. S., & Herai, R. H. (2025) · medRxiv · doi:10.1101/2025.10.22.25338597
Eslamizade, M. J., Saffarzadeh, F., & Aguilar‐Valles, A. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.12.033
Olfactory Deficits in Fragile X Syndrome
Kuruppath, P. (2026) · European Journal of Neuroscience · doi:10.1111/ejn.70357
Involvement of mGluR5/Homer crosstalk disruption in the pathophysiology of Fragile X Syndrome
Aloisi, E. (2015) · theses.fr (ABES) · doi:10.70675/e628d840zb6adz4e63z9d1fz71559b23fe24
Studying Neuronal Connectivity in the Mouse Brain in Normal Condition and Fragile X Syndrome
Haberl, M. G. (2014) · theses.fr (ABES) · doi:10.70675/cbb47168z82fbz41a1z9174zd9e36b2b5a6d
Regulation of the protein synthesis machinery in the striatum
Biever, A. (2016) · theses.fr (ABES) · doi:10.70675/d51e3b2cz4ba2z4930z8686z2d89c7f3949d
Mechanism of action of a new organometallic compound inhibitor of topoisomerase I in adenocarcinomas
Molinaro, C. (2023) · theses.fr (ABES) · doi:10.70675/98b43d98zd02bz42a9z89ebz27012480adda
Gao, P., Wu, Y., Rumpf, S.-L., Weilin, C. H. E. N., Schaffer, P., Kolb, C., Giesbertz, P., Feng, X., Rodrigues, L. D., He, Y., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10296980/v1
Convergent and Divergent Molecular Pathways in FMR1-, TSC2- and FMR1/TSC2 Knockout Neurons
Utami, K. H., Yusof, N. A. B. M., Ramaswamy, Y., Tay, S. K. H., Aishworiya, R., Tham, N., Langley, S. R., Pouladi, M. A., & Han, V. X. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06166-3
Lawal, S. A., Mujtaba, M., & Shrestha, P. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106993
BindingDB Entry 50002441: Structure-Activity Relationships and Therapeutic Potentials of 5-HT
BindingDB (2020) · UC San Diego · doi:10.7270/q2v98bpm
Metadata
- Authors
- Bhakar, A. L., Dölen, G., & Bear, M. F.
- Affiliations
- Howard Hughes Medical Institute (US)
- Stanford Medicine (US)
- Venue
- Annual Review of Neuroscience
- Publisher
- Annual Reviews
- Published
- 2012-07-21
- Volume
- 35
- Issue
- 1
- Pages
- 417-443
- ISSN
- 0147-006X (ISSN-L)
- 1545-4126
- PMC
- PMC4327822
- OpenAlex
- W2146760872
- Cited by
- 370
- References
- 207
- Citations by year
- 2026: 4 · 2025: 13 · 2024: 13 · 2023: 17 · 2022: 14 · 2021: 24 · 2020: 16 · 2019: 21 · 2018: 31 · 2017: 29 · 2016: 37 · 2015: 43 · 2014: 49 · 2013: 42 · 2012: 17
- FWCI
- 5.90
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Annual Review of Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- PMC
- Funders
- Howard Hughes Medical Institute
- National Institute of Mental Health (F30MH067431)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Keywords
- fragile X syndrome, FMRP, intellectual disability, autism spectrum disorder, metabotropic glutamate receptors, local protein synthesis, synaptic plasticity, mRNA-binding proteins
- MeSH terms
- Animals, Brain, Disease Models, Animal, Fragile X Syndrome, Gene Expression Regulation, Humans, Models, Biological, Nerve Tissue Proteins, Neuronal Plasticity, RNA, Synapses, Protein Biosynthesis, Signal Transduction, Receptors, Metabotropic Glutamate, Fragile X Mental Retardation Protein, Fragile X Messenger Ribonucleoprotein 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
